Subcutaneous administration of interleukin-2 and interferon-alpha 2b in advanced renal cell carcinoma: long-term results.
Locatelli MC, Facendola G, Pizzocaro G, Piva L, Pegoraro C, Pallavicini EB, Signaroldi A, Meregalli M, Lombardi F, Beretta GD, Scanzi F, Labianca R, Dallavalle G, Luporini G.
Locatelli MC, et al. Among authors: signaroldi a.
Cancer Detect Prev. 1999;23(2):172-6. doi: 10.1046/j.1525-1500.1999.09915.x.
Cancer Detect Prev. 1999.
PMID: 10101599
Clinical Trial.